Prothrombinase enhancement through quantitative and qualitative changes affecting very low density lipoprotein in complex with C-reactive protein

被引:20
作者
Dennis, MW
Downey, C
Brufatto, N
Nesheim, ME
Stevenson, K
Toh, CH
机构
[1] Royal Liverpool Univ Hosp, Roald Dahl Haemostasis & Thrombosis Ctr, Liverpool L7 8XP, Merseyside, England
[2] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada
关键词
DIC; lipoproteins; phospholipids; thrombin; sepsis;
D O I
10.1160/TH03-08-0548
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The biphasic waveform that can predict for disseminated intravascular coagulation (DIC) is due to the formation of a calcium-dependent complex between C reactive protein (CRP) and very low density lipoprotein (VLDL). As thrombin generation is pivotal to DIC, this aspect has been specifically investigated and the VLDL component has been found to increase prothrombinase activity via both quantitative and qualitative changes. The specific prothrombinase activity of VLDL from patients manifesting the biphasic waveform was 2.5. times that of normal individuals or critically ill patients without the biphasic waveform. This activity was due to an increase in anionic phospholipid surfaces that could be inhibited with excess annexin V and which was dependent on structurally intact apolipoprotein B. The qualitative change appeared to be due to a deficiency of phosphatidylethanolamine in VLDL from patients with the biphasic waveform. The functional consequence of this enhanced prothrombinase activity was an increased procoagulant effect in plasma. Using a modified activated partial thromboplastin time assay, the mean normal clot time decreased significantly when VLDL from patients with biphasic waveforms was substituted. These results indicate that VLDL derived from patients with the biphasic waveform can enhance thrombin procoagulant activity. As the CRP-VLDL complex exists in vivo, it could have a pathogenic role in disseminating the process of intravascular coagulation.
引用
收藏
页码:522 / 530
页数:9
相关论文
共 35 条
  • [1] Bouchard BA, 1997, J BIOL CHEM, V272, P9244
  • [2] The use of prothrombin(S525C) labeled with fluorescein to directly study the inhibition of prothrombinase by antithrombin during prothrombin activation
    Brufatto, N
    Nesheim, ME
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) : 17663 - 17671
  • [3] CABANA VG, 1989, J LIPID RES, V30, P39
  • [4] Cardiolipin is a normal component of human plasma lipoproteins
    Deguchi, H
    Fernández, JA
    Hackeng, TM
    Banka, CL
    Griffin, JH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) : 1743 - 1748
  • [5] Early identification and prognostic implications in disseminated intravascular coagulation through transmittance waveform analysis
    Downey, C
    Kazmi, R
    Toh, CH
    [J]. THROMBOSIS AND HAEMOSTASIS, 1998, 80 (01) : 65 - 69
  • [6] Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulation
    Downey, C
    Kazmi, R
    Toh, CH
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (01) : 68 - 73
  • [7] Role of phosphatidylethanolamine in assembly and function of the factor IXa-Factor VIIIa complex on membrane surfaces
    Falls, LA
    Furie, B
    Furie, BC
    [J]. BIOCHEMISTRY, 2000, 39 (43) : 13216 - 13222
  • [8] Preparations of synthetic phospholipids promote procoagulant activity on damaged vessels:: studies under flow conditions
    Galán, AM
    Hernández, MR
    Bozzo, J
    Reverter, JC
    Estelrich, J
    Roy, T
    Mazzara, R
    Ordinas, A
    Escolar, G
    [J]. TRANSFUSION, 1998, 38 (11-12) : 1004 - 1010
  • [9] Gando S, 1998, THROMB HAEMOSTASIS, V79, P1111
  • [10] STUDIES OF FACTOR-V AND FACTOR-VIII-C IN AN ANIMAL-MODEL OF DISSEMINATED INTRAVASCULAR COAGULATION
    GILES, AR
    NESHEIM, ME
    MANN, KG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (06) : 2219 - 2225